Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Genetic screens reveal novel major and minor players in magnesium homeostasis of Staphylococcus aureus.

Trachsel E, Redder P, Linder P, Armitano J.

PLoS Genet. 2019 Aug 15;15(8):e1008336. doi: 10.1371/journal.pgen.1008336. eCollection 2019 Aug.

2.

Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.

Acker G, Piper SK, Datwyler AL, Broggini T, Kremenetskaia I, Nieminen-Kelhä M, Lips J, Harms U, Mueller S, Lättig-Tünnemann G, Trachsel E, Palumbo A, Neri D, Klohs J, Endres M, Vajkoczy P, Harms C, Czabanka M.

Oncotarget. 2018 Jun 12;9(45):27760-27772. doi: 10.18632/oncotarget.25570. eCollection 2018 Jun 12.

3.

Radretumab radioimmunotherapy in patients with brain metastasis: a 124I-L19SIP dosimetric PET study.

Poli GL, Bianchi C, Virotta G, Bettini A, Moretti R, Trachsel E, Elia G, Giovannoni L, Neri D, Bruno A.

Cancer Immunol Res. 2013 Aug;1(2):134-43. doi: 10.1158/2326-6066.CIR-13-0007. Epub 2013 May 20.

4.

Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts.

Moschetta M, Pretto F, Berndt A, Galler K, Richter P, Bassi A, Oliva P, Micotti E, Valbusa G, Schwager K, Kaspar M, Trachsel E, Kosmehl H, Bani MR, Neri D, Giavazzi R.

Cancer Res. 2012 Apr 1;72(7):1814-24. doi: 10.1158/0008-5472.CAN-11-1919. Epub 2012 Mar 5.

5.

A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.

Eigentler TK, Weide B, de Braud F, Spitaleri G, Romanini A, Pflugfelder A, González-Iglesias R, Tasciotti A, Giovannoni L, Schwager K, Lovato V, Kaspar M, Trachsel E, Menssen HD, Neri D, Garbe C.

Clin Cancer Res. 2011 Dec 15;17(24):7732-42. doi: 10.1158/1078-0432.CCR-11-1203. Epub 2011 Oct 25.

6.

The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.

Schwager K, Bootz F, Imesch P, Kaspar M, Trachsel E, Neri D.

Hum Reprod. 2011 Sep;26(9):2344-52. doi: 10.1093/humrep/der195. Epub 2011 Jun 24.

7.

[Acute and long-term care. Effective prevention of decubitus ulcer allows targeted nursing].

Hürlimann B, Bühlmann J, Trachsel E, Frei IA.

Krankenpfl Soins Infirm. 2011;104(2):20-3. Review. German. No abstract available.

PMID:
21404500
8.

Microvascular biodistribution of L19-SIP in angiogenesis targeting strategies.

Czabanka M, Parmaksiz G, Bayerl SH, Nieminen M, Trachsel E, Menssen HD, Erber R, Neri D, Vajkoczy P.

Eur J Cancer. 2011 May;47(8):1276-84. doi: 10.1016/j.ejca.2011.02.001. Epub 2011 Mar 9.

PMID:
21396810
9.

In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.

Mumprecht V, Honer M, Vigl B, Proulx ST, Trachsel E, Kaspar M, Banziger-Tobler NE, Schibli R, Neri D, Detmar M.

Cancer Res. 2010 Nov 1;70(21):8842-51. doi: 10.1158/0008-5472.CAN-10-0896. Epub 2010 Oct 26.

10.

The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.

Johannsen M, Spitaleri G, Curigliano G, Roigas J, Weikert S, Kempkensteffen C, Roemer A, Kloeters C, Rogalla P, Pecher G, Miller K, Berndt A, Kosmehl H, Trachsel E, Kaspar M, Lovato V, González-Iglesias R, Giovannoni L, Menssen HD, Neri D, de Braud F.

Eur J Cancer. 2010 Nov;46(16):2926-35. doi: 10.1016/j.ejca.2010.07.033. Epub 2010 Aug 24.

PMID:
20797845
11.

Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.

Sommavilla R, Pasche N, Trachsel E, Giovannoni L, Roesli C, Villa A, Neri D, Kaspar M.

Protein Eng Des Sel. 2010 Aug;23(8):653-61. doi: 10.1093/protein/gzq038. Epub 2010 Jun 15.

PMID:
20551083
12.

[Determination of nutritional status].

Haldemann-Jenni E, Trachsel E, Zogg K, Spirig R.

Krankenpfl Soins Infirm. 2010;103(5):53. French. No abstract available.

PMID:
20518403
13.

[Malnutrition also on surgical units? Nutrition status should be assessed].

Haldemann-Jenni E, Trachsel E, Zogg K, Spirig R.

Krankenpfl Soins Infirm. 2010;103(2):32. German. No abstract available.

PMID:
20201450
14.

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.

Schwager K, Kaspar M, Bootz F, Marcolongo R, Paresce E, Neri D, Trachsel E.

Arthritis Res Ther. 2009;11(5):R142. doi: 10.1186/ar2814. Epub 2009 Sep 25.

15.

[Obesity. High demands for nursing].

Ohlhorst S, Trachsel E, Schärli D, Frei IA.

Krankenpfl Soins Infirm. 2009;102(3):30-1. German. No abstract available.

PMID:
19348363
16.

A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells.

Zuberbühler K, Palumbo A, Bacci C, Giovannoni L, Sommavilla R, Kaspar M, Trachsel E, Neri D.

Protein Eng Des Sel. 2009 Mar;22(3):169-74. doi: 10.1093/protein/gzn068. Epub 2008 Nov 20.

PMID:
19022802
17.

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

Schliemann C, Palumbo A, Zuberbühler K, Villa A, Kaspar M, Trachsel E, Klapper W, Menssen HD, Neri D.

Blood. 2009 Mar 5;113(10):2275-83. doi: 10.1182/blood-2008-05-160747. Epub 2008 Nov 12.

18.

Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.

Mårlind J, Kaspar M, Trachsel E, Sommavilla R, Hindle S, Bacci C, Giovannoni L, Neri D.

Clin Cancer Res. 2008 Oct 15;14(20):6515-24. doi: 10.1158/1078-0432.CCR-07-5041.

19.

[A nurse-led multidisciplinary malnutrition program to assess and treat patients with malnutrition or those at risk of malnutrition].

Bläuer C, Schierz-Hungerbühler J, Trachsel E, Spirig R, Frei IA.

Pflege. 2008 Aug;21(4):225-34. doi: 10.1024/1012-5302.21.4.225. Review. German.

PMID:
18677686
20.

[Objective understanding of and therapy for nutritional defects].

Trachsel E, Bläuer C, Schierz-Hungerbühler J, Frei IA.

Krankenpfl Soins Infirm. 2008;101(3):16-9. German. No abstract available.

PMID:
18610563
21.

A portable albumin binder from a DNA-encoded chemical library.

Dumelin CE, Trüssel S, Buller F, Trachsel E, Bootz F, Zhang Y, Mannocci L, Beck SC, Drumea-Mirancea M, Seeliger MW, Baltes C, Müggler T, Kranz F, Rudin M, Melkko S, Scheuermann J, Neri D.

Angew Chem Int Ed Engl. 2008;47(17):3196-201. doi: 10.1002/anie.200704936. No abstract available.

PMID:
18366035
22.

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.

Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak JN, Rösli C, Borsi L, Neri D.

Int J Cancer. 2008 Jun 1;122(11):2405-13. doi: 10.1002/ijc.23408.

23.

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models.

El-Emir E, Dearling JL, Huhalov A, Robson MP, Boxer G, Neri D, van Dongen GA, Trachsel E, Begent RH, Pedley RB.

Br J Cancer. 2007 Jun 18;96(12):1862-70. Epub 2007 May 22.

25.

Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.

Wyss MT, Spaeth N, Biollaz G, Pahnke J, Alessi P, Trachsel E, Treyer V, Weber B, Neri D, Buck A.

J Nucl Med. 2007 Apr;48(4):608-14.

26.

Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo.

von Lukowicz T, Silacci M, Wyss MT, Trachsel E, Lohmann C, Buck A, Lüscher TF, Neri D, Matter CM.

J Nucl Med. 2007 Apr;48(4):582-7.

27.

[Reading nursing Literature in English: new inputs for practicing nurses].

von Klitzing W, Stoll H, Trachsel E, Aldorf K, Bernhard A, Eze G, Spirig R.

Pflege. 2007 Feb;20(1):41-7. German.

PMID:
17294375
28.

Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.

Trachsel E, Bootz F, Silacci M, Kaspar M, Kosmehl H, Neri D.

Arthritis Res Ther. 2007;9(1):R9.

29.

A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.

Trachsel E, Kaspar M, Bootz F, Detmar M, Neri D.

J Invest Dermatol. 2007 Apr;127(4):881-6. Epub 2006 Dec 21.

30.

Ligand-based vascular targeting of disease.

Rybak JN, Trachsel E, Scheuermann J, Neri D.

ChemMedChem. 2007 Jan;2(1):22-40. Review.

PMID:
17154429
31.

Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19).

Spaeth N, Wyss MT, Pahnke J, Biollaz G, Trachsel E, Drandarov K, Treyer V, Weber B, Neri D, Buck A.

Nucl Med Biol. 2006 Jul;33(5):661-6.

PMID:
16843841
32.
33.

Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis.

Trachsel E, Neri D.

Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):735-54. Epub 2006 May 20. Review.

PMID:
16822576
34.

Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.

Fabbrini M, Trachsel E, Soldani P, Bindi S, Alessi P, Bracci L, Kosmehl H, Zardi L, Neri D, Neri P.

Int J Cancer. 2006 Apr 1;118(7):1805-13.

35.

In vitro antioxidant activity of non-cultivated vegetables of ethnic Albanians in southern Italy.

Pieroni A, Janiak V, Dürr CM, Lüdeke S, Trachsel E, Heinrich M.

Phytother Res. 2002 Aug;16(5):467-73.

PMID:
12203269

Supplemental Content

Loading ...
Support Center